- http://8.130.135.159:3000/leorawingate57
-
In June 2023, the FDA formally withdrew approval for oxandrolone for all indications, stating that possible adverse effects of the drug were sufficiently serious to warrant removal from the US market.
- Joined on
2026-04-01
There are no packages yet.
For more information on the package registry, see the documentation.